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Department of Vascular and Endovascular Surgery, Paracelsus Medical University, Nuremberg, GermanyThoracic endovascular repair (TEVR) is currently the treat-
ment of choice for acute, complicated Type B dissection, as
it confers a clear mortality advantage over open repair.1
However, for sub-acute and chronic complicated Type B
dissection, the place of TEVR is less well deﬁned. The
literature reporting TEVR outcomes in non-acute dissections
is scant (as well as heterogeneous) and most focus primarily
on the early impact of TEVR in Type B aortic dissection and
not on mid- to long-term outcomes. The aim of the VIRTUE
Registry was to monitor outcomes after TEVR for Type B
dissection with speciﬁc regard to temporal patterns of
treatment (acute, sub-acute and chronic).2 The Registry was
designed to follow patients over a 3-year period in order to
study the mid-term efﬁcacy of TEVR for Type B dissection.3
The most important ﬁnding from VIRTUE was that the
dissected aorta retained its plasticity after the classical 2-
week window had elapsed following onset of symptoms.
This is novel and suggests that patients with sub-acute
dissection may also beneﬁt from TEVR through aortic
remodeling, thereby avoiding the risks of aneurysmal
degeneration. A second message was the low dissection-
related mortality following TEVR at 3 years. This is impor-
tant, as it is still unknown whether TEVR offers similar
protection (from late aortic related mortality) as open sur-
gery.4 The third important ﬁnding was the relatively high
rate of reintervention at 3 years (especially in the chronic
dissection group), where eight out of 26 (31%) of patients
with a chronic dissection required distal extension after
their primary TEVR. In response, the VIRTUE authors
observed that patients with chronic Type B dissections
might require more extensive coverage to start with.
However, there is no compelling evidence that simple TEVR
extension confers any late beneﬁt in patients with chronic
dissection. In our opinion, the only good reason to treat a
chronic dissection is where there is evidence of degenera-
tion in association with the development of a post-
dissection aneurysm. As most post-dissection aneurysms
involve the thoraco-abdominal aorta, it does not seem
logical to expect exclusion of the aneurysm to succeed
without proper distal sealing. One durable solution mightDOI of original article: http://dx.doi.org/10.1016/j.ejvs.2014.05.007
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sealing, with preservation of the visceral vessels.5
Notwithstanding these importantmessages fromVIRTUE, it
is also important to be careful regarding overinterpretation of
its ﬁndings. This was a prospective, non-randomized, multi-
center European Clinical Registry, which included 100 patients
with Type B aortic dissection treated using the Medtronic
Valiant thoracic stent-graft. The design of the Registry sug-
gests a commercial purpose in order to demonstrate the su-
periority of theMedtronic thoracic stent-graft. Unfortunately,
the sample size was too small to enable meaningful statistical
analysis, especially for comparisons among the three tempo-
ral groups (acute, sub-acute, and chronic). In addition, pa-
tients were not enrolled consecutively, and there was no
record of how many patients were treated in each center but
not included in the Registry and why. The need for interven-
tionwas at the investigators’discretion,with little information
provided regarding the precise indication in sub-acute and
chronic dissections. Finally, because only the Valiant stent-
graft was used, one should be careful not to generalize the
results to other stent-grafts.
These limitations, plus a regret that the investigators
were unable to persuade Medtronic to fund follow-up to 5
years, were identiﬁed during the manuscript review pro-
cess. Where possible, the authors addressed these con-
cerns, but there are important lessons to be learned for
those planning similar registries in the future. Registries will
continue to play an important role in evaluating new
endovascular technologies. However, those involved in their
planning should include provision for larger numbers,
longer-term follow-up (i.e., 5 years) and a record must be
maintained of those who were not included within the
Registry. Otherwise, the outcomes may only be represen-
tative of a relatively small cohort of carefully selected pa-
tients and not generalizable to routine clinical practice.CONFLICT OF INTEREST
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